Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Statistical models for the deterioration of kidney function in a primary care population: A retrospective database analysis

OKE JL. et al, (2019), F1000Research, 8, 1618 - 1618

The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda

Chami GF. et al, (2019), PLOS Neglected Tropical Diseases, 13, e0007685 - e0007685

Associations of autozygosity with a broad range of human phenotypes

WALTERS R. et al, (2019), Nature Communications

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

HALLIDAY A. et al, (2019), For Presentation at the European Society of Cardiology on 2nd September 2019

Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.

Ference BA. et al, (2019), JAMA

Estimation of life expectancies using continuous-time multi-state models

van den Hout A. et al, (2019), Computer Methods and Programs in Biomedicine, 178, 11 - 18

Vitamin D and cause-specific vascular disease and mortality: a Mendelian randomisation study involving 99,012 Chinese and 106,911 European adults.

Huang T. et al, (2019), BMC Med, 17

Menopausal hormone therapy and 20-year breast cancer mortality.

Beral V. et al, (2019), Lancet

High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the Ovarian Cancer Cohort Consortium.

Peres LC. et al, (2019), Cancer Res

RoB 2: a revised tool for assessing risk of bias in randomised trials.

Sterne JAC. et al, (2019), BMJ, 366

C-reactive protein and ovarian cancer risk: Results from the Ovarian Cancer Cohort Consortium

ALLEN N., (2019), Cancer Research

Serious Adverse Effects of Extended-Release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial.

Haynes R. et al, (2019), Clin Ther

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

PREISS DJ. et al, (2019), BMC Cardiovascular Disorders

The transferability of lipid loci across African, Asian and European cohorts

WALTERS R. et al, (2019), Nature Communications

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.

Kunkle BW. et al, (2019), Nat Genet

Physical activity, sedentary leisure time, circulating metabolic markers and risk of major vascular diseases

Pang Y. et al, (2019), Circulation: Genomic and Precision Medicine

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Kristensen SL. et al, (2019), Lancet Diabetes Endocrinol

General and Abdominal Adiposity and Mortality in Mexico City: Prospective Study of 150 000 Adults.

Gnatiuc L. et al, (2019), Ann Intern Med

Pathophysiology and management of monoclonal gammopathy of renal significance.

Jain A. et al, (2019), Blood Adv, 3, 2409 - 2423

[Epidemiological characteristics and correlated factors of habitual snoring among Chinese aged 30 to 79 year-old].

Wei YX. et al, (2019), Zhonghua Liu Xing Bing Xue Za Zhi, 40, 917 - 923

Load More

Include forthcoming?